| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 7 | +57.14% | -2.62% | -1.34% | -1.27% | -5.57% | — |
| 14d | 7 | +57.14% | +0.86% | -0.39% | +1.25% | -1.07% | — |
| 30d | 7 | +57.14% | -1.28% | -0.78% | -0.50% | -0.04% | — |
| 60d | 7 | +0.00% | +12.87% | +3.05% | +9.82% | +17.93% | — |
| 90d | 7 | +57.14% | -3.98% | +2.48% | -6.46% | -26.30% | — |
| 180d | 7 | +57.14% | -15.43% | +2.31% | -17.74% | -27.62% | — |
| 1y | 7 | +100.00% | -48.18% | -9.95% | -38.23% | -46.21% | — |
| 2y | 7 | +100.00% | -46.96% | +3.79% | -50.75% | -57.25% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED |
|---|---|---|---|---|---|---|---|
| CERT CERTARA, INC. | SALE PRESIDENT, INTEGRATED DRUG DEV | 48,462 | $36.64 | $1.78M | 316,210 | Sep 2, 2021 | Sep 7, 2021 ↗ |
| CERT CERTARA, INC. | SALE PRESIDENT, INTEGRATED DRUG DEV | 1,900 | $34.15 | $64.9K | 364,672 | Sep 2, 2021 | Sep 7, 2021 ↗ |
| CERT CERTARA, INC. | SALE PRESIDENT, INTEGRATED DRUG DEV | 200 | $37.21 | $7.4K | 316,010 | Sep 2, 2021 | Sep 7, 2021 ↗ |
| CERT CERTARA, INC. | SALE PRESIDENT, INTEGRATED DRUG DEV | 3,900 | $33.51 | $130.7K | 366,572 | Sep 2, 2021 | Sep 7, 2021 ↗ |
| CERT CERTARA, INC. | SALE PRESIDENT, INTEGRATED DRUG DEV | 62,445 | $25.70 | $1.60M | 416,951 | Jun 11, 2021 | Jun 15, 2021 ↗ |
| CERT CERTARA, INC. | SALE PRESIDENT, INTEGRATED DRUG DEV | 400 | $26.59 | $10.6K | 370,472 | Jun 11, 2021 | Jun 15, 2021 ↗ |
| CERT CERTARA, INC. | SALE PRESIDENT, INTEGRATED DRUG DEV | 46,079 | $25.71 | $1.18M | 370,872 | Jun 11, 2021 | Jun 15, 2021 ↗ |
| CERT CERTARA, INC. | PURCHASEGRANT Stock grant | 23,810 | — | — | 464,744 | Apr 1, 2021 | Apr 9, 2021 ↗ |
| CERT CERTARA, INC. | PURCHASEGRANT Stock grant | 38,462 | — | — | 479,396 | Apr 1, 2021 | Jun 15, 2021 ↗ |